Static snapshot, generated 13 November 2026. Not updated, no live prices.

Workday (WDAY) research report

Workday is a 92.5% subscription franchise growing revenue 13.1% to $9.55B with $2.78B of FCF against $693M of net income [E0078][E0538][E0129][E0511][E0522], yet the stock is down 13.0% over 12 months and trails SPY by 24.6pp [E1077][E1075] while rivals SAP (+45.3%) and Microsoft (+30.9%) rally [WEB-4][WEB-1]. Our work points to three converging pressure points into the confirmed 2026-11-24 print: a founder-led CEO reset alongside 170 Form 4 sales and zero buys (~$333M net) [E2050][E0174][E0175][E0177], a seat model the 10-K ties to customer headcount [E0003] with disclosed federal-funding sales-cycle drag [E1896], and valuation methods that disagree by 109% (DCF $393 vs comps $188) [E0421]. The fact base (growth, cash conversion, Piotroski 8/9) is sound; the open question is whether AI-agent competition and Flex Credits pricing [E0094] change seat economics, which no evidence in the pack settles.

This is a stored Pegasus Alpha report, shown as it was written on 13 November 2026. Markers like [E0078] point to numbered items in that report's evidence pack; every claim is cited or marked as our inference. Prices and figures are as of the report date.

Investment thesis

Workday sells enterprise cloud software for people and money (HCM and finance) and, increasingly, AI agents, to more than 11,500 organisations and over 65% of the Fortune 500 [E0069][E0070]. Subscription is 92.5% of FY2026 revenue ($8.83B of $9.55B) and 97% of unearned revenue [E0078][E0081][E0097]. Revenue grew 13.1% [E0538]; FCF was $2.78B against net income of $693M [E0511][E0522]; Piotroski scores 8/9 and Altman Z is 3.52 [E1006][E1003].

What the price assumes: the stock is $196.45, down 13.0% over 12 months and 15.9% below its 52-week high, while SAP and Microsoft have rallied [E0469][E1077][E1074][WEB-4][WEB-1]. The DCF reverse-solve implies only ~5.9% annual FCF growth for five years versus 14.5% stage-one growth in the model and a 15.4% three-year revenue CAGR [E1546][E0537]. So the price embeds meaningful seat-erosion or AI-disruption risk (our inference).

What we think is going on: three threads converge before the 2026-11-24 print. First, a CEO reset (Bhusri back, Eschenbach out) [E2050] coincides with 170 insider sales, zero buys and ~$333M net sold, including David Duffield on 2026-10-09 [E0175][E0174][E0177][E0192]. Second, the model the 10-K ties to customer headcount [E0003] is exposed to federal-funding-linked sales-cycle drag in government, higher education and healthcare [E1896], while Flex Credits is a new consumption hedge [E0094]. Third, valuation work disagrees with itself: DCF $393 versus comps $188, a 109% gap, with the DCF weight halved [E0417][E0416][E0421][E0420]. The scenario SIMULATED Monte Carlo gives only 0.35% probability that fair value exceeds price [E1107].

Quality is mixed: GAAP operating margin is 7.5% versus 29.6% non-GAAP, ROIC 5.3% sits below WACC 9.2% [E0098][E0099][E0544][E1592].

Biggest risk to our read: if the print shows steady ~13% growth and early Flex Credits traction, the cheap forward multiple (14.8x) and 6.4% FCF yield [E0528][E0514] could drive a re-rating, and insider sales could prove to be routine plan activity (10b5-1 status is not in the pack). Conversely, any headcount-linked deceleration would hit a stock with 54% volatility [E1092].

Key debates and what is priced in

1. Do AI agents erode seat-based pricing? Market's take: the franchise is durable, with the question being whether Microsoft, ServiceNow, Oracle and SAP agents erode seats [E0002][E0008]. Our read: price action says investors lean towards erosion (WDAY -13.0% 12m; SAP +45.3%, MSFT +30.9%) [E1077][WEB-4][WEB-1], but the pack has no competitor win or pricing evidence, only price moves, and Workday has introduced Flex Credits as a consumption layer [E0094]. Settles: guidance and any disclosed Flex Credits traction at the 2026-11-24 print [E0133].

2. Does revenue still track customer headcount, and are federal-linked sectors a drag? Market's take: renewals are steady. Our read: the 10-K says the model is headcount-driven [E0003] and discloses extended sales cycles in federally funded sectors [E1896]; US unemployment is 4.1%, down 0.1 [E0689][E0680], so labour data are not yet hostile, and USAspending shows no WDAY contracts [GOV-3]. Settles: Q3 subscription growth and guidance versus the 13.1% FY trend [E0538], 2026-11-24.

3. Are insiders signalling anything with the CEO reset? Market's take: reset, not trouble [E0002]. Our read: 170 sells, 0 buys, ~$333M net [E0175][E0174][E0177] with Duffield selling on 2026-10-09 [E0192] while holding about 39M Class B shares [E1610]. Sales may be plan-driven; that is unknown. Settles: next Form 4 filings and the proxy, after the print.

4. Which valuation is right? Market's take: sceptical, given consensus mean $209.25, 6.5% above price [E0549][E0556]. Our read: the $393 DCF and $188 comps are 109% apart [E0421]; only comps and consensus sit near spot. Settles: reported FCF and operating margin trajectory over the next one to two quarters.

Reverse DCF: at $196.45 the market prices roughly 5.9% annual FCF growth for five years [E1551][E1546], against a model stage-one growth of 14.5%, FY2026 revenue growth of 13.1% and a three-year revenue CAGR of 15.4% [E0538][E0537]. Starting FCF in the model is $2.63B [E1544]. Forward P/E is 14.8x versus 40.0x trailing, PEG 0.57 [E0528][E0529][E0530]; EV/EBITDA is 29.2x on $958M GAAP-basis EBITDA [E0509][E0505].

Consensus: 37 analysts, mean $209.25 (6.5% above price), range $92 to $275 [E0499][E0549][E0556][E0548][E0547]. Our read: the market implies a sharp deceleration relative to history, which is the cheap-looking side of the debate, but the implied number is a model output, not a market fact. Implied margins and consensus revenue and EPS estimates by period are not in the pack.

Valuation

Model output, never a target. Blended fair value is $245.85 against a $196.45 price (+25.1%), weights comps 35%, analyst consensus 25%, DCF 20% (DCF weight halved because it sits more than 100% above price) [E0419][E0469][E0470][E0461][E0455][E0467][E0420]. Method values: DCF $393.17 (range $254.95-$592.10), comps $187.80 (range $126.45-$254.62), analyst mean $209.25 [E0466][E0465][E0463][E0460][E0459][E0457][E0454]. DCF and comps disagree by 109% [E0421], so the blended value should be treated with caution.

DCF inputs: WACC 9.18%, terminal growth 2.5%, beta 0.996, cost of equity 9.46%, net debt $1.49B, 196M shares [E1592][E1590][E1538][E1541][E1549][E1588]. The sensitivity grid runs $270 (WACC 11.2%, g 1.5%) to $715 (WACC 7.2%, g 3.5%) [E1573][E1557]. Scenario SIMULATED Monte Carlo: median $194.41, P10-P90 $106-$348, and a 0.35% probability that fair value exceeds price [E0449][E0448][E0445][E1107]. Multiples: P/S 4.7x, P/B 7.3x, EV/revenue 4.6x, FCF yield 6.4% [E0534][E0527][E0510][E0514]. Sum-of-parts is not applicable (one operating segment) [E0104]. Historical analogs: the analog engine ran with 30 neighbours but its settled output is not exposed in the pack [E1124][E1126].

The Scenario Lab gives a model range, not a target. Twelve-month DCF SIMULATED Monte Carlo P10-P90 is $106-$348 with a median of $194.41 [E0448][E0445][E0449]. Regime-weighted: soft landing (60%) median stock return +6.8%, hawkish (20%) -1.7%, recession (20%) -23.0% [E1183][E1186][E1165][E1168][E1174][E1177]. Likelihood buckets are our judgement: base most likely, bull and bear both plausible.

CaseWhat has to be trueEarly signsScenario Lab rangeLikelihood
Bull~13% growth holds, Flex Credits traction, founder reset reads as roadmap urgencyGuidance at/above trend; Flex Credits metricsUpper range to ~$348 (P90 DCF MC)Low-moderate
BaseSteady growth, no acceleration, headcount and federal sectors softGuidance in line; sales cycles unchangedMedian ~$194 (DCF MC); soft-landing median +6.8%Most likely
BearSeat pressure or AI-agent share loss; sales cycles lengthenGuidance cut; slower subscription growthLower range to ~$106 (P10 DCF MC); recession median -23.0%Moderate

Catalysts and timeline

Next earnings release: 2026-11-24, confirmed (Yahoo Finance; single non-estimated timestamp) [EARN-1][E0133][E0135].

DateEventWhy it mattersWhat to watch
2026-11-24Q3 FY27 earnings (confirmed)First print since February CEO reset and Flex Credits launchSubscription growth vs 13% trend, guidance, headcount-driven demand commentary
After printForm 4 filings170 sells and zero buys in last 180 days (~$333M net)Further Duffield or officer sales; any buys
2026-12-09 (per prediction-market commentary, unconfirmed)FOMC decisionMacro rate backdrop for software multiplesRate path; CPI 3.7%, fed funds 3.88%
OngoingAI hiring-bias litigation (Elias, N.D. Cal.)Pending docket; news reports a lost bid to dismiss (unverified)Rulings, class scope, damages disclosure

Risks

Risks by folder; likelihood buckets are our judgement.

Company overview and business model

Workday describes itself as the enterprise AI platform for managing people, money and agents, serving more than 11,500 organisations, over 75 million users under contract and more than 65% of the Fortune 500 [E0068][E0069][E0070]. Industries include financial services, government, healthcare, higher education, hospitality, manufacturing, retail, technology and transportation [E0026]. Sales are direct, through partners and via Workday Marketplace [E0092].

The durable earner is subscription: $8.833B or 92.5% of FY2026 revenue (FY2025: 91.4%), with professional services $719M or 7.5% [E0081][E0078][E0079][E0088][E0085]. Subscription is 97% of unearned revenue [E0097]. Revenue totalled $9.552B (FY2025 $8.446B, FY2024 $7.259B) [E0129][E0130][E0131]. Geography: US $7.176B (75.1%), non-US $2.376B (24.9%) [E0038][E0035][E0045][E0042]. No customer exceeded 10% of revenue or receivables [E0019][E0020]. Growth levers include Flex Credits, a new subscription-based flexible pricing model for AI solutions introduced in FY2026, and Success Plans add-ons [E0094][E0096]. Paradox and Sana were acquired and consolidated in FY2026 [E0100]. The 10-K ties the model to customer employee headcount [E0003]. Workforce is over 21,000 in 36 countries [E0050]. Key suppliers are not named in Item 1 [E0027]; the graph shows AWS and Google Cloud as third-party suppliers [G-1][G-2].

Industry and competitive position

The 10-K describes enterprise application software, including AI-powered solutions, as rapidly evolving, highly competitive and subject to consolidation [E0015][E0018]. Named competitors: Oracle and SAP as large vendors [E0016], plus Anaplan, ADP, Coupa, Dayforce, Microsoft, NetSuite, ServiceNow and UKG [G-9][G-14][G-20][G-3][G-4][G-8][G-17][G-13]. Peer analysis also lists Salesforce and Paylocity on product overlap [E0779][E0787].

Market size and share data are not in the pack, so we cannot quantify share trends. What the pack does show is relative price performance: over the 120-day window, SAP +45.3%, Microsoft +30.9%, ADP +21.6%, Oracle +1.3% and ServiceNow -1.7%, versus WDAY 12-month -13.0% [WEB-4][WEB-1][WEB-5][WEB-3][WEB-2][E1077]. Our inference is that investors currently favour broad platforms over single-category application vendors; this is not confirmed by competitor win data. Moat on a sliding scale: strong switching costs implied by 97% subscription share of unearned revenue and 65%+ Fortune 500 penetration [E0097][E0070], tempered by seat-pricing exposure to AI-agent platforms.

Management, governance, government and insiders

In February 2026 Aneel Bhusri, formerly Executive Chair, assumed the CEO role and Carl Eschenbach ceased to serve as CEO [E2050][G-41][G-42]. Bhusri is Co-Founder, CEO and Chair, with voting rights over about 8M Class B and 0.4M Class A shares [E1632]. Co-Founder and CEO Emeritus David Duffield holds voting rights over about 39M Class B and 0.1M Class A shares [E1610]. Aggregate insider ownership is 2.1% and institutions hold 109% of float-adjusted shares per the data vendor [E0516][E0517]. Dual-class structure is implied by the Class B holdings; governance risk is that founder control and insider supply (Duffield sold on 2026-10-09 [E0192]) coexist with a leadership reset. Person-to-person links, board composition, pay versus performance and related-party deals are not in the pack. We frame this as an evidence-backed governance risk, not an accusation against any named person.

Form 4 (SEC): 170 sells, 0 buys, ~$333M net sold over the 180-day window; the 50 filings checked include David Duffield selling on 2026-10-09 at about $186-$191 per share across several lines, the CFO and Chief Accounting Officer selling in October [E0173][E0175][E0174][E0177][E0192][E0233][E0183]. Duffield holds voting rights over about 39M Class B shares and Bhusri about 8M [E1610][E1632]. 10b5-1 status is not in the pack.

Lobbying: 9 filings in three years totalling about $300K (amended filings can repeat amounts); the Q3 2026 filings cover budget, privacy, labour and science issues [GOV-2][GOV-12]. Congress trades, federal contracts, FDA decisions, clinical trials, federal rules and physical signals were checked and found nothing for WDAY [GOV-1][GOV-3][GOV-4][GOV-5][GOV-7][GOV-8]. The GOV-6 Form 4 summary reports nothing in two years, conflicting with the 170 sells in the catalysts feed; we rely on the primary Form 4 lines [E0184][E0191].

Financial analysis and model summary

Growth: revenue rose from $7.259B (FY2024) to $8.446B to $9.552B (FY2026), +13.1% YoY with a 15.4% three-year CAGR [E0131][E0130][E0129][E0538][E0537]; TTM revenue growth is 12.8% [E0554]. Margins: gross margin 75.7% [E0515]; GAAP operating income was $721M (7.5%) versus $415M (4.9%) a year earlier; non-GAAP $2.8B (29.6%) versus $2.2B (25.9%) [E0098][E0099]. Share-based comp is heavy (e.g. $690M in product development) [E0103].

Cash conversion: FCF $2.777B versus net income $693M; three-year average FCF $2.30B [E0511][E0522][E0512]. Operating cash flow was $2.939B [E0495]. Returns: ROIC 5.3% versus WACC 9.2% [E0544][E1592]; ROE 8.2% [E0542].

Balance sheet: net debt $1.486B, net debt/EBITDA 1.55x, debt/equity 0.38, interest cover 6.3x [E0520][E0521][E0503][E0518]. Current ratio is 1.32 on one basis and 0.91 on another [E0502][E1038]. No debt maturity ladder is in the pack. Capital allocation: share count down 0.4% YoY, no dividend [E0545][E0504]; acquisitions of Paradox and Sana in FY2026 [E0100].

Quality scores: Piotroski 8/9 (only the liquidity test failed), Altman Z 3.52 in the safe zone [E1006][E1017][E1003][E1004]. Story versus numbers: the cash story is strong, the GAAP earnings and return-on-capital story is not; the gap is largely stock compensation.

Only the summary lines below are in the pack; full standardised statements and TTM columns are not. Source cross-checks between SEC and Yahoo match exactly for revenue, net income, total assets and operating cash flow at 2026-01-31 [E0473][E0479][E0485][E0491].

MetricValue
Revenue$9.552B
Revenue growth YoY13.1%
Gross margin75.7%
GAAP / non-GAAP operating margin7.5% / 29.6%
Net income$693M
FCF$2.777B (29.1% margin)
Net debt / EBITDA1.55x
ROIC vs WACC5.3% vs 9.2%
Piotroski / Altman Z8/9 / 3.52
LineFY2024FY2025FY2026
Revenue7,259M8,446M9,552M
Subscription services6,603M7,718M8,833M
Professional services656M728M719M
Net incomen/an/a693M
Operating cash flown/an/a2,939M
Total assetsn/an/a18,074M

ESG and red-flag checklist

Thresholds are ours and stated per row.

By our count: 2 red, 5 amber, 4 green, 3 unknown on the checklist. Top three: net insider selling of ~$333M with zero buys [E0177][E0174]; GAAP operating margin 7.5% with ROIC below WACC [E0098][E0544]; DCF and comps divergence of 109% [E0421]. See the Red-flag checklist section.

ItemStatusThresholdSource
Cash flow vs net incomeGreenFCF >= net incomeE0511, E0522
Piotroski / AltmanGreenPiotroski >= 7; Z > 2.99E1006, E1003
Customer concentrationGreenNo customer > 10% of revenueE0020
Net debt / EBITDAGreen< 3xE0521
Insider sellingRedNet selling with zero buys over 180 daysE0175, E0174, E0177
ROIC vs cost of capitalRedROIC below WACCE0544, E1592
GAAP vs non-GAAP margin gapAmberGap > 15pp (22pp here)E0098, E0099
DCF vs comps divergenceAmberGap > 50% (109% here)E0421
Pending litigation (AI hiring bias)AmberAny active class-type docketLEG-2
Sales-cycle drag in federal sectorsAmberDisclosed in 10-KE1896
Leadership changeAmberCEO change within 12 monthsE2050
Liquidity trendAmberPiotroski liquidity test failedE1017
Debt maturities / covenantsUnknownNo schedule in packn/a
10b5-1 status of insider salesUnknownNot disclosed in packn/a
Board independence / related-party dealsUnknownNo proxy data in packn/a

What we could not find

Unknown stays unknown. These gaps were listed in the report itself.

  • Debt maturities, covenants and RPO/cRPO are not in the pack (affects Financial and Risks sections).
  • 10b5-1 plan status of insider sales is unknown (affects Government and insiders and the insider chain).
  • Proxy data (board, pay, related-party deals, outside ties) is missing (affects Management and governance).
  • No competitor product, win or pricing evidence beyond price moves; Oracle headlines were empty and GDELT was rate-limited (affects Industry and the competition chain).
  • Market size, growth and share trends are not in the pack (affects Industry).
  • Consensus revenue and EPS estimates by period are missing (affects What's priced in).
  • ML analog settled output and live hit rate are not exposed (affects Quant and ML signals).
  • MiroFish runs returned no Workday content; no simulation-derived chain exists (affects Scenario simulation).
  • Earnings-call transcript unavailable and FINRA bi-monthly short-interest file not exposed (affects management directness and positioning read).
  • Full five-year-plus-TTM financial statements are not in the pack (affects Financial analysis and Appendix).
  • Current ratio conflicts across sources (1.32 vs 0.91) and prices come from an unofficial source (affects balance-sheet and price reads).
  • Web map truncated to 40 of 82 edges (affects the completeness of 3-hop threads).
  • Industry and competitive position: No market-size, growth or share-trend data in the pack; competitor evidence is price moves only, Oracle headlines were empty, and GDELT news was rate-limited. Carried to Gaps.
  • Financial analysis: Only three fiscal years of revenue and one year of full statement detail appear in the pack (not five plus TTM); no debt maturity schedule, RPO or cRPO. Carried to Gaps.
  • Estimates and what's priced in: Implied margins and period-by-period consensus revenue and EPS estimates are not in the pack, so the consensus gap against our base case cannot be quantified. Carried to Gaps.
  • Quant and ML signals: The analog engine's settled matches and any live hit rate are not exposed in the pack; the engine is flagged report-context only [E1126].
  • Scenario simulation: All three simulation runs returned no Workday-specific reactions because the OASIS environment was not running; nothing from simulation is used elsewhere in the report.
  • Management and governance: No proxy data: board independence, executive pay versus performance, related-party transactions and outside ties of the officers are not in the pack.
  • Appendix: financial statements: Full five-year-plus-TTM income statement, balance sheet and cash flow line items are not in the pack; only headline lines are available.
  • Key debates and what is priced in: Part of the underlying data is missing: Implied margins and period-by-period consensus revenue and EPS estimates are not in the pack, so the consensus gap against our base case cannot be quantified. Carried to Gaps.
  • Industry and competitive position: Part of the underlying data is missing: No market-size, growth or share-trend data in the pack; competitor evidence is price moves only, Oracle headlines were empty, and GDELT news was rate-limited. Carried to Gaps.
  • Management, governance, government and insiders: Part of the underlying data is missing: No proxy data: board independence, executive pay versus performance, related-party transactions and outside ties of the officers are not in the pack.
  • Financial analysis and model summary: Part of the underlying data is missing: Only three fiscal years of revenue and one year of full statement detail appear in the pack (not five plus TTM); no debt maturity schedule, RPO or cRPO. Carried to Gaps.; Full five-year-plus-TTM income statement, balance sheet and cash flow line items are not in the pack; only headline lines are available.

Disclosures

  • Pegasus Alpha is a research tool. This report is not investment advice and is not an offer or a solicitation to buy or sell any security.
  • Pegasus Alpha gives no rating and no price target. Where a range is shown it is a model range, not a target.
  • Every claim is cited to the evidence pack or marked as inference. Evidence tiers 1 to 5 apply; anything below tier 3 is unconfirmed.
  • Anything marked SIMULATED comes from a simulation. Simulations are never evidence.
  • Figures come from the public sources listed in the Sources section, as they were available on the date of the run. Gaps are listed in the Gaps section.